- Home
- SHIP vs PLX Comparison
SHIP vs PLX Comparison
Compare SHIP & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHIP
- PLX
- Stock Information
- Founded
- SHIP 2008
- PLX 1993
- Country
- SHIP Greece
- PLX United States
- Employees
- SHIP N/A
- PLX N/A
- Industry
- SHIP Marine Transportation
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SHIP Consumer Discretionary
- PLX Health Care
- Exchange
- SHIP Nasdaq
- PLX Nasdaq
- Market Cap
- SHIP 153.8M
- PLX 127.4M
- IPO Year
- SHIP 2007
- PLX 1998
- Fundamental
- Price
- SHIP $9.01
- PLX $1.85
- Analyst Decision
- SHIP Strong Buy
- PLX Strong Buy
- Analyst Count
- SHIP 1
- PLX 1
- Target Price
- SHIP $11.00
- PLX $15.00
- AVG Volume (30 Days)
- SHIP 136.6K
- PLX 692.9K
- Earning Date
- SHIP 11-04-2025
- PLX 11-13-2025
- Dividend Yield
- SHIP 8.55%
- PLX N/A
- EPS Growth
- SHIP N/A
- PLX N/A
- EPS
- SHIP 0.73
- PLX 0.08
- Revenue
- SHIP $147,718,000.00
- PLX $61,948,000.00
- Revenue This Year
- SHIP N/A
- PLX $14.53
- Revenue Next Year
- SHIP $12.15
- PLX $75.77
- P/E Ratio
- SHIP $11.86
- PLX $23.89
- Revenue Growth
- SHIP 1.66
- PLX 62.79
- 52 Week Low
- SHIP $4.78
- PLX $0.99
- 52 Week High
- SHIP $12.65
- PLX $3.10
- Technical
- Relative Strength Index (RSI)
- SHIP 73.15
- PLX 62.58
- Support Level
- SHIP $8.62
- PLX $1.52
- Resistance Level
- SHIP $8.88
- PLX $1.97
- Average True Range (ATR)
- SHIP 0.25
- PLX 0.09
- MACD
- SHIP 0.05
- PLX 0.03
- Stochastic Oscillator
- SHIP 94.08
- PLX 73.33
About SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Geniuship, Premiership, Squireship, And Friendship.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.